Author

David D.F. Ma

Professor - Cited by 11,527

Biography

David D.F. Ma, belonging to Blood Stem Cells and Cancer Research, St Vincent’s Centre for Applied Medical Research, and The University of New South Wales, Sydney, New South Wales 2010, Australia. Interested in the field of Stem cell therapy.
Title
Cited by
Year
Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study
A Younes, J Brody, C Carpio, A Lopez-Guillermo, D Ben-Yehuda, ...The Lancet Haematology 6 (2), e67-e78, 2019201
158
2019
Regenerating immunotolerance in multiple sclerosis with autologous hematopoietic stem cell transplant
JC Massey, IJ Sutton, DDF Ma, JJ MooreFrontiers in immunology 9, 410, 2018201
74
2018
Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis
JJ Moore, JC Massey, CD Ford, ML Khoo, JJ Zaunders, K Hendrawan, ...Journal of Neurology, Neurosurgery & Psychiatry 90 (5), 514-521, 2019201
69
2019
miR-10a as a therapeutic target and predictive biomarker for MDM2 inhibition in acute myeloid leukemia
TT Vu, F Stölzel, KW Wang, C Röllig, ML Tursky, TJ Molloy, DD MaLeukemia 35 (7), 1933-1948, 212
20
2021
Direct comparison of four hematopoietic differentiation methods from human induced pluripotent stem cells
ML Tursky, TH Loi, CM Artuz, S Alateeq, EJ Wolvetang, H Tao, DD Ma, ...Stem cell reports (3), 735-748, 2020202
15
2020
Dealing with the spiralling price of medicines: issues and solutions
CKK Ma, M Danta, R Day, DDF MaInternal medicine journal 48 (1), 16-24, 2018201
11
2018
Poor prognosis in patients with steroid refractory acute graft versus host disease treated with etanercept: a multi-centre analysis
CKK Ma, I García-Cadenas, ML Fox, S Ai, I Nivison-Smith, ST Milliken, ...Bone marrow transplantation 53 (11), 1478-1482, 2018201
10
2018
Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic
D Purtill, C Hutchins, G Kennedy, A McClean, C Fraser, PJ Shaw, ...Transplantation and Cellular Therapy 27 (12), 22. e1-22. e6, 2021202
10
2021
Sustained immunotolerance in multiple sclerosis after stem cell transplant
M Visweswaran, K Hendrawan, JC Massey, ML Khoo, CD Ford, ...Annals of clinical and translational neurology (2), 206-220, 2022202
9
2022
Unrelated donor transplant recipients given thymoglobuline have superior GRFS when compared to matched related donor recipients undergoing transplantation without ATG
J Othman, M Greenwood, J Moore, S Larsen, AM Watson, C Arthur, ...Biology of Blood and Marrow Transplantation 26 (10), 1868-1875, 2020202
9
2020
Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseases
K Hendrawan, M Visweswaran, DDF Ma, JJ MooreBone Marrow Transplantation 55 (5), 57-66, 2020202
8
2020
Hematopoietic stem cell transplant recipients surviving at least 2 years from transplant have survival rates approaching population levels in the modern era of transplantation
D Kliman, I Nivison-Smith, D Gottlieb, N Hamad, I Kerridge, D Purtill, ...Biology of Blood and Marrow Transplantation 26 (9), 1711-171, 2020202
8
2020
Autologous hematopoietic stem cell transplantation for behcet’s disease: a retrospective survey of patients treated in europe, on behalf of the Autoimmune Diseases Working …
M Puyade, A Patel, YJ Lim, N Blank, M Badoglio, F Gualandi, DD Ma, ...Frontiers in Immunology 12, 38709, 2021202
6
2021
Favorable Outcome of Lung Transplantation for Severe Pulmonary Graft Versus Host Disease: An Australian Multicenter Case Series
DS Kliman, SR Kotecha, DC Abelson, GI Snell, AR Glanville, DDF MaTransplantation 103 (12), 202-207, 2019201
6
2019
Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis
S Chatterton, B Withers, IJ Sutton, ST Milliken, DDF Ma, JJ Moore, ...Multiple Sclerosis Journal 27 (13), 2112-2115, 2021202
6
2021
Haematopoietic stem cell transplantation results in extensive remodelling of the clonal T cell repertoire in multiple sclerosis
J Massey, K Jackson, M Singh, B Hughes, B Withers, C Ford, M Khoo, ...Frontiers in Immunology 13, 232, 2022202
6
2022
Activity and capacity profile of transplant physicians and centers in Australia and New Zealand
I Nivison-Smith, S Milliken, AJ Dodds, D Gottlieb, J Kwan, DDF Ma, ...Biology of Blood and Marrow Transplantation 24 (1), 169-174, 2018201
3
2018
Where there’sa will, there’sa way: establishing hematopoietic stem cell transplantation in Myanmar
AA Gyi, R Mra, HL Nyein, T Aung, N Win, PT Khin, S Issaragrisil, ...Blood Advances 1 (Suppl 1), 65, 2017201
3
2017
Successful long-term TMA-and rejection-free survival of a kidney xenograft with triple xenoantigen knockout plus insertion of multiple human transgenes
D Ma, T Hirose, I Rosales, H Sasaki, R Colvin, J Markmann, W Qin, Y Kan, ...Transplantation 104 (S), S82, 2020202
3
2020
Induction of muscle-regenerative multipotent stem cells from human adipocytes by PDGF-AB and 5-azacytidine
A Yeola, S Subramanian, RA Oliver, CA Lucas, JAI Thoms, F Yan, ...Science advances 7 (3), eabd199, 010
2
2021

Referred From: https://scholar.google.com/citations?user=uv2H5k0AAAAJ&hl=en

Cited by
Citations 11527
h-index 43
i10-index 92
Recommended Journals
Open Access Journals